Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Internal Medicine (Tokyo, Japan)|March 13, 2018
Chronic Hepatitis C Treatment with Daclatasvir Plus Asunaprevir Does Not Lead to a Decreased Quality of LifeMegumi Kawakubo, Yuichiro Eguchi, Michiaki Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 4, 2012
Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenibTaiga Otsuka, Yuichiro Eguchi, Seiji Kawazoe, et al.
Pancreas|May 23, 2013
Gemcitabine in patients with intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreasTaiga Otsuka, Chigusa Morizane, Satoshi Nara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 31, 2015
Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatmentSaori Kamachi, Toshihiko Mizuta, Taiga Otsuka, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 29, 2018
Asunaprevir and daclatasvir in hemodialysis patients with chronic hepatitis C virus genotype 1b infectionTaiga Otsuka, Yasunori Kawaguchi, Toshihiko Mizuta, et al.
Journal of Gastroenterology|February 22, 2012
Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trialTaiga Otsuka, Seiji Kawazoe, Shunya Nakashita, et al.
Cancer Science|September 15, 2016
Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairmentTakuji Okusaka, Taiga Otsuka, Hideki Ueno, et al.
Internal Medicine (Tokyo, Japan)|October 16, 2015
Efficacy and safety of telaprevir, pegylated interferon α-2b and ribavirin triple therapy in Japanese patients infected with hepatitis C virus genotype 1bYasunori Kawaguchi, Shinji Iwane, Takanori Kumagai, et al.
Digestive Diseases and Sciences|February 3, 2009
Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral loadToshihiko Mizuta, Yasunori Kawaguchi, Yuichiro Eguchi, et al.
Internal Medicine (Tokyo, Japan)|December 16, 2015
Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot TrialShinji Iwane, Toshihiko Mizuta, Yasunori Kawaguchi, et al.
Pageof 5